CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment

BACKGROUND: Definitive concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced non-small cell lung cancer (LANSCLC) patients, but the treatment response and survival outcomes varied among these patients. We aimed to identify pretreatment computed tomography-based radiomics...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Nai-Bin, Xiong, Mai, Zhou, Rui, Zhou, Yin, Qiu, Bo, Luo, Yi-Feng, Zhou, Su, Chu, Chu, Li, Qi-Wen, Wang, Bin, Jiang, Hai-Hang, Guo, Jin-Yu, Peng, Kang-Qiang, Xie, Chuan-Miao, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667605/
https://www.ncbi.nlm.nih.gov/pubmed/36384755
http://dx.doi.org/10.1186/s13014-022-02136-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667605/
https://www.ncbi.nlm.nih.gov/pubmed/36384755
http://dx.doi.org/10.1186/s13014-022-02136-w

Ejemplares similares